Abstract
Abstract
Background
The COVID-19 pandemic has created a crisis in access to addiction treatment. Programs with residential components have been particularly impacted as they try to keep infection from spreading in facilities and contributing to further community spread of the virus. This crisis highlights the ongoing daily trade-offs that organizations must weigh as they balance the risks and benefits of individual patients with those of the group of patients, staff and the community they serve.
Main body
The COVID-19 pandemic has forced provider organizations to make individual facility level decisions about how to manage patients who are COVID-19 positive while protecting other patients, staff and the community. While guidance documents from federal, state, and trade groups aimed to support such decision making, they often lagged pandemic dynamics, and provided too little detail to translate into front line decision making. In the context of incomplete knowledge to make informed decisions, we present a way to integrate guidelines and local data into the decision process and discuss the ethical dilemmas faced by provider organizations in preventing infections and responding to COVID positive patients or staff.
Conclusion and commentary
Provider organizations need decision support on managing the risk of COVID-19 positive patients in their milieu. While useful, guidance documents may not be capable of providing support with the nuance that local data and simulation modeling may be able to provide.
Funder
National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Naguchi Y. A new addiction crisis: treatment centers face financial collapse, all things considered. Washington: National Public radio; 2020.
2. Wan W, Long H. Cries for help: drug overdoses are soaring during the coronavirus pandemic. Washington: Washington Post; 2020.
3. Knopf A. NAATP urges members to urge staff to get COVID-19 vaccine. ADAW. 2021;33(3):5–6.
4. Bridges v. HOUSTON METHODIST HOSPITAL, Civil Action No. H-21-1774 (S.D. Tex. June 12, 2021).
5. Mellis AM, Kelly BC, Potenza MN, Hulsey JN. Trust in a COVID-19 vaccine among people with substance use disorders. Drug Alcohol Depend. 2021;220:108519.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献